BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 34775577)

  • 21. A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction.
    Marumo K; Imaoka T; Fujimoto K; Watts S; Stothard D; McGill J
    J Sex Med; 2007 May; 4(3):745-752. PubMed ID: 17087800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
    Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG
    J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
    J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of once-daily tadalafil on confidence and perceived difficulty in performing sexual intercourse in men who were incomplete responders to as-needed PDE5 inhibitor treatment.
    Seftel AD; Rosen RC; Hayes RP; Althof S; Goldfisher E; Shen W; Sontag A
    Int J Clin Pract; 2014 Jul; 68(7):841-9. PubMed ID: 24666765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Adjusted Dose Tadalafil for Treating Erectile Dysfunction in Patients on Chronic Hemodialysis.
    Ozgur BC; Keseroglu BB
    Arch Esp Urol; 2022 Jun; 75(5):400-404. PubMed ID: 35983809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma.
    Incrocci L; Slagter C; Slob AK; Hop WC
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):439-44. PubMed ID: 16965992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.
    Nagao K; Kimoto Y; Marumo K; Tsujimura A; Vail GM; Watts S; Ishii N; Kamidono S
    Urology; 2006 Oct; 68(4):845-51. PubMed ID: 17070365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of tadalafil in clinical populations.
    Lewis RW; Sadovsky R; Eardley I; O'Leary M; Seftel A; Wang WC; Shen W; Walker DJ; Wong DG; Ahuja S
    J Sex Med; 2005 Jul; 2(4):517-31. PubMed ID: 16422847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily.
    Rubio-Aurioles E; Kim ED; Rosen RC; Porst H; Burns P; Zeigler H; Wong DG
    J Sex Med; 2009 May; 6(5):1314-23. PubMed ID: 19473285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS).
    Gomery P; Bullock A; McGettigan J; Munarriz R; Natanegara F; Hague J; Kuepfer C; Ahuja S; Wong D
    Int J Impot Res; 2007; 19(1):76-83. PubMed ID: 16728966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction.
    Seftel AD; Wilson SK; Knapp PM; Shin J; Wang WC; Ahuja S
    J Urol; 2004 Aug; 172(2):652-7. PubMed ID: 15247754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis.
    Guo YL; Viswanathan VP; Chiang HS; Choi HK; Yip AW; Shen W; Kopernicky V
    Asian J Androl; 2009 Jul; 11(4):423-33. PubMed ID: 19377488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.
    Hatzichristou D; Gambla M; Rubio-Aurioles E; Buvat J; Brock GB; Spera G; Rose L; Lording D; Liang S
    Diabet Med; 2008 Feb; 25(2):138-46. PubMed ID: 18290855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.
    Saylan M; Khalaf I; Kadioglu A; Shoair KZ; Beheiry A; Wang WC; Kopernicky V; Esen A
    Int J Clin Pract; 2006 Jul; 60(7):812-9. PubMed ID: 16846400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction.
    McMahon CG; Carson CC; Fischer CJ; Wang WC; Florio VA; Bradley JD
    J Sex Med; 2006 May; 3(3):504-11. PubMed ID: 16681476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.